Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) |  Citable Docs. (3years) |
Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Neuropsychopharmacology Reports | journal | 0.660 Q2 | 22 | 105 | 201 | 3867 | 480 | 199 | 2.40 | 36.83 |  |
| 52 | Behavioural Pharmacology | journal | 0.455 Q3 | 87 | 49 | 197 | 2397 | 323 | 193 | 1.67 | 48.92 | |
| 53 | Journal of Biopharmaceutical Statistics | journal | 0.812 Q2 | 56 | 110 | 203 | 3340 | 285 | 189 | 1.07 | 30.36 | |
| 54 | Cannabis and Cannabinoid Research | journal | 0.932 Q2 | 42 | 173 | 194 | 8890 | 873 | 183 | 4.16 | 51.39 | |
| 55 | Vascular Pharmacology | journal | 0.969 Q1 | 108 | 66 | 187 | 3575 | 665 | 183 | 3.64 | 54.17 | |
| 56 | Journal of Pharmacological and Toxicological Methods | journal | 0.428 Q3 | 83 | 48 | 165 | 2160 | 250 | 162 | 1.29 | 45.00 | |
| 57 | Journal of NeuroImmune Pharmacology | journal | 1.396 Q1 | 91 | 47 | 180 | 3170 | 941 | 156 | 4.59 | 67.45 | |
| 58 | Biologicals | journal | 0.452 Q3 | 66 | 42 | 154 | 1276 | 287 | 152 | 1.49 | 30.38 | |
| 59 | Prostaglandins and Other Lipid Mediators | journal | 0.671 Q2 | 86 | 56 | 156 | 3893 | 431 | 151 | 2.43 | 69.52 | |
| 60 | Journal of Immunotherapy | journal | 1.263 Q1 | 106 | 44 | 150 | 1376 | 521 | 149 | 3.12 | 31.27 | |
| 61 | American Journal of Therapeutics | journal | 0.544 Q3 | 69 | 133 | 510 | 2694 | 449 | 146 | 0.81 | 20.26 | |
| 62 | Clinical Neuropharmacology | journal | 0.287 Q3 | 85 | 44 | 156 | 1416 | 149 | 146 | 0.81 | 32.18 | |
| 63 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.694 Q2 | 70 | 55 | 154 | 2186 | 403 | 144 | 2.25 | 39.75 | |
| 64 | Current Therapeutic Research | journal | 0.495 Q3 | 46 | 37 | 110 | 1384 | 214 | 108 | 1.60 | 37.41 | |
| 65 | Annual Review of Pharmacology and Toxicology | journal | 3.957 Q1 | 224 | 32 | 103 | 4593 | 1346 | 103 | 11.26 | 143.53 | |
| 66 | Pharmacological Reviews | journal | 6.050 Q1 | 254 | 35 | 102 | 13259 | 2111 | 100 | 19.42 | 378.83 | |
| 67 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.255 Q3 | 34 | 32 | 88 | 1098 | 151 | 88 | 1.45 | 34.31 | |
| 68 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
| 69 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | |
| 70 | Drug Topics | journal | 0.104 Q4 | 8 | 104 | 412 | 180 | 2 | 71 | 0.01 | 1.73 | |
| 71 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.536 Q3 | 82 | 17 | 53 | 3290 | 172 | 53 | 2.83 | 193.53 | |
| 72 | Topics in antiviral medicine | journal | 0.614 Q2 | 46 | 18 | 36 | 403 | 63 | 36 | 1.89 | 22.39 | |
| 73 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 | |
| 74 | Food and Drug Law Journal | journal | 0.145 Q4 | 23 | 12 | 14 | 1814 | 4 | 14 | 0.29 | 151.17 | |
| 75 | Current Protocols in Pharmacology | journal | 0.670 Q2 | 39 | 0 | 11 | 0 | 30 | 11 | 0.00 | 0.00 | |
| 76 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q2 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | |
| 77 | Journal of Caffeine and Adenosine Research | journal | 0.112 Q4 | 1 | 0 | 8 | 0 | 1 | 5 | 0.13 | 0.00 | |
| 78 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | |
| 79 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | |
| 80 | NTP Developmental and Reproductive Toxicity Technical Report Series | book series | 0.111 Q4 | 1 | 0 | 11 | 0 | 0 | 3 | 0.00 | 0.00 | |
| 81 | NTP Immunotoxicity Technical Report Series | book series | 0.133 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data